Skip to main content
  • Search
  • My LSTM
  • LSTM
  • Who Are We?
    • Meet the Team
    • Partners
  • Target Diseases
    • Lymphatic Filariasis
    • Onchocerciasis
  • Why A∙WOL?
    • The A∙WOL Approach
    • Existing Treatment Options
    • Tylosin Analogue Macrofilaricides (TylAMac™)
  • Projects
    • Publications
  • News & Events
    • Public Engagement
Search
  • Who Are We?
    • Meet the Team
    • Partners
  • Target Diseases
    • Lymphatic Filariasis
    • Onchocerciasis
  • Why A∙WOL?
    • The A∙WOL Approach
    • Existing Treatment Options
    • Tylosin Analogue Macrofilaricides (TylAMac™)
  • Projects
    • Publications
  • News & Events
    • Public Engagement

Primary tabs

  • Latest
  • News
  • Events
  • Media(active tab)
  • Home
  • News & Events
  • Media

Primary tabs

  • Latest
  • News
  • Events
  • Media(active tab)

Media

Media 25 Jan 2016 Bill Gates visits A∙WOL Lab Bill Gates, George Osborne and Justine Greening paid a visit to the A∙WOL Lab during the official announcement of the Ross Fund
Media 15 Apr 2015 NTD drug discovery the A·WOL experience: macrofilaricides for onchocerciasis and LF. Mark Taylor From: LSTM Session from: Addressing the chronic pandemic of neglected tropical diseases the first decade & onwardsWednesday, 15th April 2015 - Leggate...

Find us

Find out about visiting us

Contact us

Elly Wallis - Project Coordinator
A·WOL Consortium
Liverpool School of Tropical Medicine
Pembroke Place
Liverpool
L3 5QA 

e-mail: awol@lstmed.ac.uk 
phone: +44(0)151 705 2532
twitter: @AWOL_Wolbachia
instagram: @a.wol.consortium

 

Find out about visiting us
  • Cookies
  • Disclaimer
  • Sitemap
  • Terms of use
© 2025 AWOL
Website by Manta Ray Media